KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Payables (2016 - 2025)

Astrana Health (ASTH) has disclosed Payables for 15 consecutive years, with $195.9 million as the latest value for Q4 2025.

  • Quarterly Payables rose 83.47% to $195.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $195.9 million through Dec 2025, up 83.47% year-over-year, with the annual reading at $195.9 million for FY2025, 83.47% up from the prior year.
  • Payables hit $195.9 million in Q4 2025 for Astrana Health, down from $209.7 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $209.7 million in Q3 2025 to a low of $11.7 million in Q2 2021.
  • Historically, Payables has averaged $77.4 million across 5 years, with a median of $52.2 million in 2023.
  • Biggest YoY gain for Payables was 477.49% in 2021; the steepest drop was 53.5% in 2021.
  • Year by year, Payables stood at $44.5 million in 2021, then grew by 12.85% to $50.2 million in 2022, then increased by 20.63% to $60.6 million in 2023, then skyrocketed by 76.24% to $106.8 million in 2024, then surged by 83.47% to $195.9 million in 2025.
  • Business Quant data shows Payables for ASTH at $195.9 million in Q4 2025, $209.7 million in Q3 2025, and $119.7 million in Q2 2025.